Want to see HCAT full AI Analyst Report?
Health Catalyst (HCAT) Stock Statistics & Valuation Metrics
Total Valuation
Health Catalyst has a market cap or net worth of $111.19M. The enterprise value is $68.12M.
- Market Cap
- $111.19M
- Enterprise Value
- $68.12M
Share Statistics
Health Catalyst has 76,155,464 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 76,155,464
- Owned by Insiders
- 10.79%
- Owned by Institutions
- 22.75%
Financial Efficiency
Health Catalyst’s return on equity (ROE) is -0.72 and return on invested capital (ROIC) is -8.63%.
- Return on Equity (ROE)
- -0.72
- Return on Assets (ROA)
- -0.35
- Return on Invested Capital (ROIC)
- -8.63%
- Return on Capital Employed (ROCE)
- -0.09
- Revenue Per Employee
- 259.28K
- Profits Per Employee
- -148.31K
- Employee Count
- 1,200
- Asset Turnover
- 0.62
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Health Catalyst is -0.54. Health Catalyst’s PEG ratio is 0.01.
- PE Ratio
- -0.54
- PS Ratio
- 0.42
- PB Ratio
- 0.78
- Price to FCF
- 4.42
- Price to Operating Cash Flow
- 4.24
- PEG Ratio
- 0.01
Income Statement
In the last 12 months, Health Catalyst had revenue of 311.14M and earned -177.97M in profits. Earnings per share was -2.55.
- Revenue
- 311.14M
- Gross Profit
- 104.13M
- Operating Income
- -36.10M
- Pretax Income
- -177.26M
- Net Income
- -177.97M
- EBITDA
- -110.35M
- Earnings Per Share (EPS)
- -2.55
Cash Flow
In the last 12 months, operating cash flow was 26.82M and capital expenditures -1.11M, giving a free cash flow of 25.71M billion.
- Operating Cash Flow
- 26.82M
- Free Cash Flow
- 25.71M
- Free Cash Flow per Share
- 0.34
Dividends & Yields
Health Catalyst pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 22.70%
- Earnings Yield
- -178.12%
Stock Price Statistics
- Beta
- 1.39
- 52-Week Price Change
- -50.68%
- 50-Day Moving Average
- 1.71
- 200-Day Moving Average
- 1.68
- Relative Strength Index (RSI)
- 38.22
- Average Volume (3m)
- 500.53K
Important Dates
Health Catalyst upcoming earnings date is Mar 02, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 05, 2026
- Next Earnings Date
- Mar 02, 2027
- Ex-Dividend Date
- ―
Financial Position
Health Catalyst as a current ratio of 1.89, with Debt / Equity ratio of 69.67%
- Current Ratio
- 1.89
- Quick Ratio
- 1.89
- Debt to Market Cap
- 0.92
- Net Debt to EBITDA
- -1.09
- Interest Coverage Ratio
- -2.20
Taxes
In the past 12 months, Health Catalyst has paid 716.00K in taxes.
- Income Tax
- 716.00K
- Effective Tax Rate
- -0.00
Enterprise Valuation
Health Catalyst EV to EBITDA ratio is -0.52, with an EV/FCF ratio of 2.93.
- EV to Sales
- 0.28
- EV to EBITDA
- -0.52
- EV to Free Cash Flow
- 2.93
- EV to Operating Cash Flow
- 2.81
Balance Sheet
Health Catalyst has $78.99M in cash and marketable securities with $15.75M in debt, giving a net cash position of $63.24M billion.
- Cash & Marketable Securities
- $78.99M
- Total Debt
- $15.75M
- Net Cash
- $63.24M
- Net Cash Per Share
- $0.83
- Tangible Book Value Per Share
- $1.12
Margins
Gross margin is 44.80%, with operating margin of 3.74%, and net profit margin of -74.24%.
- Gross Margin
- 44.80%
- Operating Margin
- 3.74%
- Pretax Margin
- -73.98%
- Net Profit Margin
- -74.24%
- EBITDA Margin
- -53.33%
- EBIT Margin
- -84.94%
Analyst Forecast
The average price target for Health Catalyst is $1.65, which is 11.43% higher than the current price. The consensus rating is Neutral
- Price Target
- $1.65
- Price Target Upside
- 13.01% Upside
- Analyst Consensus
- Neutral
- Analyst Count
- 4
- Revenue Growth Forecast
- -13.88%
- EPS Growth Forecast
- -78.38%
Scores
- Smart Score
- 4
- AI Score
- 51

